Epigenetic therapy and cisplatin chemoradiation in FIGO stage IIIB cervical cancer.

Candelaria, M; Cetina, L; Pérez-Cárdenas, E; de la Cruz-Hernández, E; González-Fierro, A; Trejo-Becerril, C; Taja-Chayeb, L; Chanona, J; Arias, D; Dueñas-González, A

Candelaria, M; Cetina, L; Pérez-Cárdenas, E; de la Cruz-Hernández, E; González-Fierro, A; Trejo-Becerril, C; Taja-Chayeb, L; Chanona, J; Arias, D; Dueñas-González, A.

Affiliation

Candelaria M; Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas (IIB), Universidad Nacional Autonóma de Mexico (UNAM), Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.

Eur J Gynaecol Oncol ; 31(4): 386-91, 2010.

Article in En | MEDLINE | ID: mdl-20882878

Subject(s)

Antineoplastic Agents/therapeutic use; Brachytherapy; Cisplatin/therapeutic use; Epigenesis, Genetic; Uterine Cervical Neoplasms/therapy; Adult; Aged; Brachytherapy/adverse effects; Cisplatin/adverse effects; Combined Modality Therapy; Female; Humans; Hydralazine/administration & dosage; Middle Aged; Neoplasm Staging; Uterine Cervical Neoplasms/genetics; Uterine Cervical Neoplasms/mortality; Uterine Cervical Neoplasms/pathology; Valproic Acid/administration & dosage

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Brachytherapy / Uterine Cervical Neoplasms / Cisplatin / Epigenesis, Genetic / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Middle aged Language: En Year: 2010 Type: Article

Search on Google

XML

PubMed Links